Connacht Asset Management LP Johnson & Johnson Transaction History

Connacht Asset Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $523,841 - $625,141	-3,468 Reduced 57.52%	2,561 $396,000
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $148,665 - $166,845	-928 Reduced 13.34%	6,029 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $358,959 - $399,432	-2,225 Reduced 24.23%	6,957 $1.14 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $1.54 Million - $1.71 Million	9,182 New	9,182 $1.63 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.